Back to search

Article

Subtype-specific HERV-K102 envelope is a novel serum immunosuppressive biomarker and therapeutic target of cancer

2024-05-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Immune dysfunction is a hallmark of cancer and plays critical roles in immunotherapy resistance, but there is no serum biomarker that can be used to evaluate immune-dysfunction status of cancer patients. Here, we identified subtype-specific HERV-K102 envelope (K102-Env) with immunosuppressive activity in circulating blood as a novel serum immunosuppressive bioma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
07e67082-d0d6-5134-9f4e-bdb819f1ca58
DOI
10.21203/rs.3.rs-4381830/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Subtype-specific HERV-K102 envelope is a novel serum immunosuppressive biomarker and therapeutic target of cancerDOI 10.21203/rs.3.rs-4381830/v1
Select a neighboring publication to make it the new centre.